Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
NTRA Natera, Inc. daily Stock Chart
NTRA [NASD]
Natera, Inc.
Healthcare | Diagnostics & Research | USA
statements
Index- P/E- EPS (ttm)-1.72 Insider Own1.90% Shs Outstand78.29M Perf Week10.10%
Market Cap4.34B Forward P/E- EPS next Y-2.34 Insider Trans-20.35% Shs Float74.79M Perf Month7.48%
Income-126.10M PEG- EPS next Q-0.68 Inst Own93.24% Short Float8.20% Perf Quarter21.34%
Sales329.50M P/S13.18 EPS this Y19.00% Inst Trans4.49% Short Ratio7.58 Perf Half Y48.68%
Book/sh3.31 P/B15.97 EPS next Y8.30% ROA-26.50% Target Price62.33 Perf Year65.79%
Cash/sh4.94 P/C10.70 EPS next 5Y- ROE-70.50% 52W Range16.87 - 56.51 Perf YTD56.93%
Dividend- P/FCF- EPS past 5Y- ROI-29.40% 52W High-6.44% Beta1.27
Dividend %- Quick Ratio2.70 Sales past 5Y13.70% Gross Margin46.20% 52W Low213.40% ATR2.45
Employees1039 Current Ratio2.80 Sales Q/Q40.70% Oper. Margin-36.20% RSI (14)61.92 Volatility5.16% 4.87%
OptionableYes Debt/Eq0.48 EPS Q/Q16.70% Profit Margin-38.30% Rel Volume0.68 Prev Close55.17
ShortableYes LT Debt/Eq0.28 EarningsAug 05 AMC Payout- Avg Volume808.82K Price52.87
Recom1.70 SMA209.04% SMA5013.93% SMA20037.74% Volume551,704 Change-4.17%
Jun-10-20Resumed Piper Sandler Overweight $56 → $63
May-07-20Upgrade JP Morgan Neutral → Overweight $32 → $45
Oct-05-18Initiated JP Morgan Neutral $26
Jul-05-18Reiterated Piper Jaffray Overweight $18 → $21
Aug-07-17Reiterated Morgan Stanley Overweight $18 → $13
Nov-10-16Reiterated The Benchmark Company Buy $16 → $20
May-23-16Reiterated The Benchmark Company Buy $15 → $16
May-11-16Reiterated The Benchmark Company Buy $14 → $15
Apr-19-16Initiated The Benchmark Company Buy $14
Sep-28-15Upgrade Wedbush Neutral → Outperform
Aug-14-15Upgrade Morgan Stanley Equal-Weight → Overweight
Aug-04-15Initiated Robert W. Baird Outperform $20
Jul-27-15Initiated Wedbush Neutral $20
Jul-27-15Initiated Piper Jaffray Overweight $24
Jul-27-15Initiated Morgan Stanley Equal-Weight $20
Aug-07-20 09:03AM  
Natera Files Additional Suit Against ArcherDX
PR Newswire
Aug-05-20 06:35PM  
Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates
Zacks
04:05PM  
Natera Reports Second Quarter 2020 Financial Results
PR Newswire
Aug-04-20 09:41AM  
Healthcare Stock Q2 Earnings Roster for Aug 5: HUM, CRL & More
Zacks
Aug-03-20 11:20AM  
New Publication in Nature Cancer Demonstrates Signatera's Ability to Evaluate Tumor Response to Immunotherapy
PR Newswire
Jul-29-20 12:33PM  
Analysts Estimate Natera (NTRA) to Report a Decline in Earnings: What to Look Out for
Zacks
09:03AM  
Natera Announces Second Quarter 2020 Earnings Conference Call
PR Newswire
Jul-14-20 12:33PM  
Natera Inc (NTRA): Are Hedge Funds Right About This Stock?
Insider Monkey +5.23%
09:03AM  
Natera Recognized as a 'Force for Change' by Leading Women Entrepreneurs (LWE)
PR Newswire
Jun-22-20 09:03AM  
Natera Expands Lab Footprint With State-Of-The-Art Facility in Austin, Texas
PR Newswire
Jun-18-20 09:05AM  
Natera Announces First Patient Enrollments in Both CIRCULATE-Japan and BESPOKE CRC Trials Using Signatera MRD Testing
PR Newswire
Jun-17-20 12:22PM  
Natera Files Patent Suit Against Progenity, Inc.
PR Newswire
Jun-09-20 02:45AM  
Edited Transcript of NTRA earnings conference call or presentation 6-May-20 8:30pm GMT
Thomson Reuters StreetEvents
Jun-08-20 12:52PM  
Edited Transcript of NTRA earnings conference call or presentation 26-Feb-20 9:30pm GMT
Thomson Reuters StreetEvents
Jun-05-20 11:35AM  
Here is What Hedge Funds Think About Natera Inc (NTRA)
Insider Monkey
Jun-02-20 10:00AM  
Moving Average Crossover Alert: Natera
Zacks
Jun-01-20 09:07AM  
Natera Launches Quantification Technique to Enhance Prospera Test Precision; Initiates PEDAL Study for New Insights
PR Newswire
May-26-20 10:08AM  
Natera Announces New Prospera Data at ATC Showcasing Innovation in Cell-Free DNA
PR Newswire
May-19-20 09:03AM  
Natera Announces New Data at ASCO Highlighting Utility of Personalized MRD Monitoring
PR Newswire
May-18-20 09:03AM  
Natera and Illumina Settle Patent Dispute
PR Newswire
May-13-20 09:03AM  
Natera to Present at the UBS Virtual Global Healthcare Conference
PR Newswire
May-11-20 02:40PM  
Prospera Receives Positive Medicare Coverage
PR Newswire +6.89%
May-08-20 11:46AM  
7 Strong Buy Healthcare Stocks to Buy Now
InvestorPlace
07:32AM  
Natera (NTRA) Q1 2020 Earnings Call Transcript
Motley Fool
May-06-20 07:25PM  
Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates
Zacks
04:05PM  
Natera Reports First Quarter 2020 Financial Results
PR Newswire
May-05-20 10:35AM  
Is a Surprise Coming for Natera (NTRA) This Earnings Season?
Zacks
May-04-20 09:05AM  
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Natera, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
PR Newswire
09:03AM  
Natera Announces Achievement of Key Recruitment Milestones in ProActive Study and Success in Prospera Early Access Program
PR Newswire
Apr-29-20 09:03AM  
Natera Announces First Quarter 2020 Earnings Conference Call
PR Newswire
Apr-15-20 09:23AM  
Natera Asserts Three New Oncology Patents Against ArcherDX
PR Newswire
Apr-14-20 12:03AM  
Natera Prices $250 Million Convertible Senior Notes Due 2027
PR Newswire
Apr-13-20 12:04PM  
Is Natera (NASDAQ:NTRA) Weighed On By Its Debt Load?
Simply Wall St. -7.24%
07:11AM  
Natera to Offer $250 Million Convertible Senior Notes Due 2027
PR Newswire
07:04AM  
Natera Announces Preliminary First Quarter 2020 Financial Results
PR Newswire
Apr-06-20 09:04AM  
Coverage for Natera's Panorama® Prenatal Test Extended by Greater Than 20 Million Lives
PR Newswire +9.96%
Apr-02-20 09:15AM  
New Study Shows Benefit of Using Signatera Technology for Personalized Monitoring in Gastrointestinal Cancer
PR Newswire +5.12%
Mar-28-20 08:53PM  
Hedge Funds Have Never Been This Bullish On Natera Inc (NTRA)
Insider Monkey
Mar-23-20 06:13PM  
Natera Scores Relative Strength Rating Upgrade; Hits Key Benchmark
Investor's Business Daily -7.41%
Mar-22-20 11:03AM  
Three stocks that are part of the solution to the coronavirus crisis
MarketWatch
Mar-19-20 09:03AM  
Natera Provides Remote Access to Tests Without Requiring Live Office Visits
PR Newswire +39.95%
Mar-04-20 09:05AM  
Natera to Showcase Leadership in Cell-Free DNA at CEoT Conference
PR Newswire +9.87%
Mar-03-20 09:14AM  
Natera to Participate in Upcoming Investor Conferences
PR Newswire
09:03AM  
Natera Receives Favorable Medicare Reimbursement Pricing for Prospera
PR Newswire
Feb-26-20 07:25PM  
Natera (NTRA) Reports Q4 Loss, Tops Revenue Estimates
Zacks
05:25PM  
1955 Capitals Andrew Chung: Why ClimateTech Is Heating Up in Venture Capital
IPO-Edge.com
04:10PM  
Natera Reports Fourth Quarter and Year 2019 Financial Results
PR Newswire
Feb-19-20 08:57PM  
Natera Announces Fourth Quarter and Fiscal 2019 Earnings Conference Call
PR Newswire
Feb-18-20 09:20AM  
Natera Files False Advertising Counterclaim Against CareDx
PR Newswire
Feb-11-20 09:05AM  
Elicio Therapeutics and Natera to Collaborate in Phase I/II Pancreatic Cancer Study of ELI-002
PR Newswire
09:05AM  
Elicio Therapeutics and Natera To Collaborate in Phase I/II Pancreatic Cancer Study of ELI-002
Business Wire
Jan-27-20 09:13AM  
Natera Files Suit Against ArcherDX for Patent Infringement
PR Newswire
Jan-15-20 08:42AM  
National Cancer Center Japan Launches Multi-Center Randomized Trial Using Signatera MRD Testing in Stage II-III Colorectal Cancer
PR Newswire
Jan-14-20 12:35AM  
Edited Transcript of NTRA earnings conference call or presentation 6-Nov-19 9:30pm GMT
Thomson Reuters StreetEvents
Jan-13-20 09:26AM  
Natera Announces New Early Priority Date cfDNA Patent, Files Suit Against CareDx
PR Newswire
Jan-09-20 09:05AM  
Natera Launches BESPOKE CRC Study to Evaluate Outcomes in 1,000 Signatera Patients with Stage II-III Colorectal Cancer
PR Newswire
Jan-08-20 07:35AM  
Natera To Webcast Live Presentation at the 38th Annual J.P. Morgan Healthcare Conference
PR Newswire
Jan-06-20 08:30AM  
Natera Announces Achievement of $55 Million In Pharma Contracts and Issuance of New Oncology Patents
PR Newswire
Dec-19-19 11:32AM  
Natera Receives Final Medicare Coverage for Prospera Organ Transplant Rejection Assessment Test
PR Newswire +5.66%
Dec-07-19 05:36PM  
Hedge Funds Have Never Been This Bullish On Natera Inc (NTRA)
Insider Monkey
Nov-27-19 08:20AM  
Panorama Publication Demonstrates Utility of Measuring Individual Fetal Fractions in Twin Pregnancies
PR Newswire
Nov-15-19 07:21AM  
What Kind Of Share Price Volatility Should You Expect For Natera, Inc. (NASDAQ:NTRA)?
Simply Wall St.
Nov-06-19 06:25PM  
Natera (NTRA) Reports Q3 Loss, Tops Revenue Estimates
Zacks
04:05PM  
Natera Reports Third Quarter 2019 Financial Results
PR Newswire
Oct-30-19 07:03AM  
Natera Announces Third Quarter 2019 Earnings Conference Call
PR Newswire
Oct-25-19 10:11AM  
Hedge Funds Are Betting On Natera Inc (NTRA)
Insider Monkey
Oct-16-19 10:00PM  
Natera Announces Pricing of Follow-On Offering
PR Newswire -7.45%
Oct-15-19 06:10PM  
Natera stock falls after hours on secondary-offering announcement
MarketWatch
05:46PM  
Natera Launches Proposed Follow-On Offering
PR Newswire
Oct-03-19 08:45AM  
Natera to Host Investor Conference Call to Discuss Progress in its Oncology Business
PR Newswire
Sep-26-19 09:47AM  
Natera (NTRA) Scales 52-Week High: What's Driving the Stock?
Zacks
Sep-25-19 09:03AM  
Foundation Medicine and Natera Partner to Advance Personalized Cancer Monitoring
PR Newswire
Sep-13-19 11:45AM  
CBR® Acquires Evercord Newborn Stem Cell Business from Natera
PR Newswire
11:45AM  
CBR to Acquire Natera's Evercord Cord Blood Business
PR Newswire
Sep-09-19 11:01AM  
Natera Publishes Largest NIPT Outcomes Study Demonstrating Robust Clinical Performance Over a 4-year Period
PR Newswire -7.55%
Sep-05-19 10:06AM  
Did Natera, Inc. (NASDAQ:NTRA) Insiders Sell Shares?
Simply Wall St.
Sep-04-19 09:03AM  
Natera to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
PR Newswire
Aug-29-19 09:16AM  
Natera Appoints Rowan Chapman to its Board of Directors
PR Newswire
Aug-28-19 09:43AM  
Natera to Webcast Live Presentation at the Baird 2019 Global Healthcare Conference
PR Newswire
Aug-22-19 01:13PM  
Medicare Issues Positive Draft Local Coverage Determination for Natera's Signatera MRD Test in Colorectal Cancer
PR Newswire
09:16AM  
Panorama NIPT Achieves 2 Million Test Milestone
PR Newswire
Aug-14-19 06:37AM  
Edited Transcript of NTRA earnings conference call or presentation 7-Aug-19 8:30pm GMT
Thomson Reuters StreetEvents -7.68%
Aug-12-19 09:15PM  
Natera Inc (NTRA) CEO Steven Leonard Chapman Sold $3.3 million of Shares
GuruFocus.com -9.48%
Aug-07-19 05:35PM  
Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates
Zacks
04:07PM  
Natera Reports Second Quarter 2019 Financial Results
PR Newswire
Aug-05-19 08:02AM  
Publication Demonstrates Unique Ability of Panorama Test to Determine Zygosity in Twin Pregnancies
PR Newswire -6.28%
Jul-31-19 08:51PM  
Natera Announces Second Quarter 2019 Earnings Conference Call
PR Newswire
Jul-22-19 02:38PM  
Is Natera's (NASDAQ:NTRA) Share Price Gain Of 104% Well Earned?
Simply Wall St.
Jul-12-19 05:26PM  
Here's Why Natera Stock Soared 97.6% in the First Half of 2019
Motley Fool
Jun-24-19 08:07AM  
New ProActive Study From Natera Will Test for Rejection in 3,000 Kidney Transplant Recipients
PR Newswire
Jun-19-19 06:41PM  
46 and You: Genetic Testing = Giant Growth Market
Zacks
06:00PM  
Did Hedge Funds Drop The Ball On Natera Inc (NTRA) ?
Insider Monkey
07:27AM  
Natera, Inc.'s Shares March Higher, Can It Continue?
Zacks
Jun-13-19 07:57PM  
Edited Transcript of NTRA earnings conference call or presentation 9-May-19 8:30pm GMT
Thomson Reuters StreetEvents
Jun-06-19 06:59AM  
What Kind Of Shareholder Owns Most Natera, Inc. (NASDAQ:NTRA) Stock?
Simply Wall St.
Jun-03-19 08:34AM  
Data Presented at ASCO Shows Natera's Signatera Test Detects Immunotherapy Treatment Response in Metastatic Cancers
PR Newswire
May-22-19 09:27AM  
Natera, Inc. (NTRA) Shares March Higher, Can It Continue?
Zacks
May-21-19 09:40AM  
Noridian Posts Favorable Draft Local Coverage Determination for Natera's Prospera Kidney Transplant Test
PR Newswire
May-20-19 10:20AM  
OncoCyte (OCX) Catches Eye: Stock Jumps 7.3%
Zacks
May-10-19 02:24PM  
Natera (NTRA) Q1 2019 Earnings Call Transcript
Motley Fool +22.25%
Natera, Inc. provides preconception and prenatal genetic testing services. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum pre-implantation genetic screening and Spectrum pre-implantation genetic diagnosis to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora products of conception test to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by analyzing the fragments of fetal deoxyribonucleic acid in a pregnant mother's blood and a blood sample from the alleged father. In addition, it offers Constellation, a cloud-based software product that allows laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests; Evercord, a cord blood and cord tissue processing and storage service; and Signatera, a circulating tumor DNA technology that analyzes and tracks mutations to an individual's tumor. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners in the United States and internationally. Natera, Inc. has research collaborations with the Institut Jules Bordet and Fox Chase Cancer Center; and a partnership agreement with Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays for use by biopharmaceutical and clinical customers. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is headquartered in San Carlos, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brophy Michael BurkesChief Financial OfficerJul 22Option Exercise10.411,62616,92745,771Jul 24 06:10 PM
Brophy Michael BurkesChief Financial OfficerJul 22Sale49.031,62679,72344,145Jul 24 06:10 PM
Rabinowitz MatthewExecutive ChairmanJul 14Sale45.981084,9661,110,311Jul 15 07:16 PM
Schueren Robert AlanChief Operating OfficerJul 08Sale47.001,98793,38942,429Jul 09 08:26 PM
Chapman Steven LeonardChief Executive OfficerJul 06Sale48.361,55975,39323,814Jul 07 06:25 PM
Chapman Steven LeonardChief Executive OfficerJul 02Option Exercise13.019,376121,98237,051Jul 07 06:25 PM
Chapman Steven LeonardChief Executive OfficerJul 02Sale49.0611,678572,87525,373Jul 07 06:25 PM
Schueren Robert AlanChief Operating OfficerJul 01Option Exercise13.0115,000195,15055,432Jul 06 06:37 PM
Schueren Robert AlanChief Operating OfficerJul 01Sale50.0015,000750,00040,432Jul 06 06:37 PM
Sheena JonathanChief Technology OfficerJun 30Option Exercise10.1592,115935,314341,185Jul 02 05:57 PM
Sheena JonathanChief Technology OfficerJun 30Sale49.4492,1154,554,221249,070Jul 02 05:57 PM
Chapman Steven LeonardChief Executive OfficerJun 24Sale45.474,771216,95524,550Jun 25 06:23 PM
Brophy Michael BurkesChief Financial OfficerJun 24Sale45.7710,021458,63544,145Jun 25 06:22 PM
Schueren Robert AlanChief Operating OfficerJun 24Sale45.476,362289,28440,432Jun 25 06:25 PM
Schueren Robert AlanChief Operating OfficerJun 23Option Exercise0.0012,500046,794Jun 25 06:25 PM
Chapman Steven LeonardChief Executive OfficerJun 23Sale45.511,67176,04819,946Jun 23 08:42 PM
Rabinowitz MatthewExecutive ChairmanJun 23Sale45.511426,4631,109,805Jun 23 08:47 PM
Sheena JonathanChief Technology OfficerJun 23Sale45.512069,375249,070Jun 23 08:44 PM
Brophy Michael BurkesChief Financial OfficerJun 23Sale45.512,728124,15141,666Jun 23 08:38 PM
Chapman Steven LeonardChief Executive OfficerJun 22Option Exercise13.0131,250406,56360,413Jun 23 08:42 PM
Brophy Michael BurkesChief Financial OfficerJun 22Sale46.4744820,81942,768Jun 23 08:38 PM
Sheena JonathanChief Technology OfficerJun 22Sale46.4749923,189249,276Jun 23 08:44 PM
Chapman Steven LeonardChief Executive OfficerJun 22Sale45.0939,3541,774,27821,617Jun 23 08:42 PM
Chapman Steven LeonardChief Executive OfficerJun 16Option Exercise11.924,16949,70329,755Jun 17 07:03 PM
Chapman Steven LeonardChief Executive OfficerJun 16Sale45.004,457200,56525,298Jun 17 07:03 PM
Chapman Steven LeonardChief Executive OfficerJun 15Option Exercise11.924,16949,70330,043Jun 17 07:03 PM
Rabinowitz MatthewExecutive ChairmanJun 15Sale41.9097640,8941,109,547Jun 17 08:19 PM
Chapman Steven LeonardChief Executive OfficerJun 15Sale40.714,457181,43025,586Jun 17 07:03 PM
Brophy Michael BurkesChief Financial OfficerJun 10Sale42.191,19750,50141,022Jun 10 07:51 PM
Sheena JonathanChief Technology OfficerJun 10Sale42.191,02343,160248,203Jun 10 07:57 PM
Chapman Steven LeonardChief Executive OfficerJun 10Sale42.191,14648,35025,874Jun 10 07:53 PM
Chapman Steven LeonardChief Executive OfficerJun 09Sale39.5716,158639,44624,724Jun 10 07:53 PM
Schueren Robert AlanChief Operating OfficerJun 09Sale39.5712,927511,49734,294Jun 10 07:58 PM
Brophy Michael BurkesChief Financial OfficerJun 09Sale39.589,076359,18339,198Jun 10 07:51 PM
Brophy Michael BurkesChief Financial OfficerMay 22Option Exercise10.413,25133,84326,525May 27 06:18 PM
Brophy Michael BurkesChief Financial OfficerMay 22Sale45.453,251147,75223,274May 27 06:18 PM
Marcus Gail BoxerDirectorMay 18Sale45.997,278334,7110May 20 06:34 PM
Sheena JonathanChief Technology OfficerMay 12Option Exercise10.097,88579,595251,786May 14 05:52 PM
Sheena JonathanChief Technology OfficerMay 12Sale49.057,885386,746246,935May 14 05:52 PM
Schueren Robert AlanChief Operating OfficerMay 07Option Exercise13.0115,000195,15037,221May 11 07:55 PM
Sheena JonathanChief Technology OfficerMay 07Option Exercise7.11100,000710,787305,070May 11 07:57 PM
Brophy Michael BurkesChief Financial OfficerMay 07Sale40.0083333,32023,274May 11 08:00 PM
Sheena JonathanChief Technology OfficerMay 07Sale43.44100,0004,344,405246,935May 11 07:57 PM
Schueren Robert AlanChief Operating OfficerMay 07Sale40.0015,000600,00022,221May 11 07:55 PM
Schueren Robert AlanChief Operating OfficerApr 08Sale30.211,98860,05722,221Apr 09 07:04 PM
Brophy Michael BurkesChief Financial OfficerApr 06Option Exercise10.182,25122,92026,358Apr 08 02:28 PM
Brophy Michael BurkesChief Financial OfficerApr 06Sale29.012,25165,30224,107Apr 08 02:28 PM
Chapman Steven LeonardChief Executive OfficerApr 03Sale27.501,56443,0099,632Apr 06 04:43 PM
Brophy Michael BurkesChief Financial OfficerMar 23Sale24.101,38133,28624,107Mar 24 06:23 PM
Sheena JonathanChief Technology OfficerMar 23Sale24.1089721,617246,935Mar 24 06:20 PM
Rabinowitz MatthewExecutive ChairmanMar 23Sale24.0957913,9461,107,705Mar 24 06:19 PM
Chapman Steven LeonardChief Executive OfficerMar 23Sale24.107,424178,8878,071Mar 24 06:18 PM
Rabinowitz MatthewExecutive ChairmanMar 10Sale33.361,10736,9301,106,684Mar 11 06:49 PM
Brophy Michael BurkesChief Financial OfficerMar 10Sale33.3678726,25420,061Mar 11 05:37 PM
Sheena JonathanChief Technology OfficerMar 10Sale33.3680026,688244,895Mar 11 05:36 PM
Chapman Steven LeonardChief Executive OfficerMar 10Sale33.361,14738,2641,150Mar 11 05:33 PM
Brophy Michael BurkesChief Financial OfficerMar 04Sale40.0047418,96017,827Mar 04 06:01 PM
Brophy Michael BurkesChief Financial OfficerMar 02Option Exercise10.182,25122,92020,552Mar 04 06:01 PM
Brophy Michael BurkesChief Financial OfficerMar 02Sale37.542,25184,50318,301Mar 04 06:01 PM
Brophy Michael BurkesChief Financial OfficerFeb 27Sale40.002008,00018,301Feb 28 05:05 PM
Brophy Michael BurkesChief Financial OfficerFeb 03Option Exercise10.182,25122,92020,752Feb 04 05:26 PM
Brophy Michael BurkesChief Financial OfficerFeb 03Sale35.222,25179,28018,501Feb 04 05:26 PM
Chapman Steven LeonardChief Executive OfficerJan 16Option Exercise11.55116,6181,346,845139,340Jan 17 09:15 PM
Chapman Steven LeonardChief Executive OfficerJan 16Sale35.00139,3404,876,9000Jan 17 09:15 PM
Rabinowitz MatthewExecutive ChairmanJan 14Sale33.481274,2521,204,973Jan 15 04:21 PM
HEALY JAMESDirectorJan 10Option Exercise11.1122,338248,06329,616Jan 14 04:13 PM
Schueren Robert AlanChief Operating OfficerJan 08Sale34.998,167285,76320,225Jan 09 05:12 PM
Chapman Steven LeonardChief Executive OfficerJan 07Option Exercise9.591,84917,73224,571Jan 08 06:51 PM
Chapman Steven LeonardChief Executive OfficerJan 07Sale35.001,84964,71522,722Jan 08 06:51 PM
Chapman Steven LeonardChief Executive OfficerJan 03Sale32.014,739151,69022,722Jan 06 05:42 PM
Brophy Michael BurkesChief Financial OfficerJan 02Option Exercise9.596255,99419,126Jan 02 07:28 PM
Brophy Michael BurkesChief Financial OfficerJan 02Sale33.8662521,16318,501Jan 02 07:28 PM
Brophy Michael BurkesChief Financial OfficerDec 30Option Exercise10.232,86029,26021,361Jan 02 07:28 PM
Brophy Michael BurkesChief Financial OfficerDec 30Sale33.632,86096,18218,501Jan 02 07:28 PM
Chapman Steven LeonardChief Executive OfficerDec 23Sale36.9355820,60714,961Dec 23 06:49 PM
Sheena JonathanChief Technology OfficerDec 23Sale36.9350018,465243,403Dec 23 06:49 PM
Brophy Michael BurkesChief Financial OfficerDec 23Sale36.9344316,36018,501Dec 23 06:48 PM
Rabinowitz MatthewExecutive ChairmanDec 18Sale35.6016,856600,1031,204,793Dec 18 06:41 PM
Rabinowitz MatthewExecutive ChairmanDec 17Sale37.5033,3331,249,9141,221,649Dec 18 06:41 PM
Sheena JonathanChief Technology OfficerDec 16Option Exercise4.37100,000436,892305,305Dec 18 06:41 PM
Rabinowitz MatthewExecutive ChairmanDec 16Sale37.7333,3331,257,6581,254,982Dec 18 06:41 PM
Sheena JonathanChief Technology OfficerDec 16Sale37.69100,0003,769,416242,786Dec 18 06:41 PM
Chapman Steven LeonardChief Executive OfficerDec 10Sale36.131,14841,47814,402Dec 11 04:11 PM
Brophy Michael BurkesChief Financial OfficerDec 10Sale36.131,19943,32117,827Dec 11 04:11 PM
Rabinowitz MatthewExecutive ChairmanDec 10Sale36.131,40950,9081,288,315Dec 11 04:11 PM
Sheena JonathanChief Technology OfficerDec 10Sale36.131,02737,106242,786Dec 11 04:10 PM
Brophy Michael BurkesChief Financial OfficerNov 29Option Exercise10.232,85929,25018,864Dec 03 04:27 PM
Brophy Michael BurkesChief Financial OfficerNov 29Sale37.502,859107,21316,005Dec 03 04:27 PM
Brophy Michael BurkesChief Financial OfficerOct 30Option Exercise10.232,85929,25018,864Nov 01 04:14 PM
Brophy Michael BurkesChief Financial OfficerOct 30Sale38.252,859109,35716,005Nov 01 04:14 PM
Brophy Michael BurkesChief Financial OfficerOct 21Sale40.0015,701628,04016,005Oct 23 04:23 PM
Rabinowitz MatthewExecutive ChairmanOct 14Sale38.201485,6531,286,906Oct 15 04:22 PM
Brophy Michael BurkesChief Financial OfficerSep 30Option Exercise10.014,03240,37135,738Oct 02 05:28 PM
Brophy Michael BurkesChief Financial OfficerSep 30Sale32.014,032129,06431,706Oct 02 05:28 PM
Sheena JonathanChief Technology OfficerSep 23Sale33.5350016,765241,521Sep 24 05:02 PM
Brophy Michael BurkesChief Financial OfficerSep 23Sale33.5344414,88731,706Sep 24 05:01 PM
Chapman Steven LeonardChief Executive OfficerSep 23Sale33.5355918,74413,254Sep 24 05:02 PM
Chapman Steven LeonardChief Executive OfficerSep 20Sale33.199,424312,75712,696Sep 23 07:07 PM
Schueren Robert AlanChief Operating OfficerSep 20Sale33.1912,545416,33512,455Sep 23 07:07 PM
Brophy Michael BurkesChief Financial OfficerSep 20Sale33.199,972330,94431,033Sep 23 07:04 PM
open in yahoo | open in reuters | open in google